Company Overview of BioMarck Pharmaceuticals, Ltd.
BioMarck Pharmaceuticals, Ltd., a biopharmaceutical company, discovers and develops drugs for the treatment of pulmonary diseases and disorders associated with the over-secretion of mucus and pulmonary inflammation. The company develops BIO-11006 Inhalation Solution that inhibits the function of the myristoylated alaninerich C kinase substrate, which is a vital component for secretion of mucus and inflammatory mediators. Its product also targets chronic obstructive pulmonary disease, as well as other diseases, such as asthma and cystic fibrosis. BioMarck Pharmaceuticals, Ltd. was founded in 2002 and is based in Durham, North Carolina.
Westpark Corporate Center
4364 South Alston Avenue
Durham, NC 27713-2280
Founded in 2002
Key Executives for BioMarck Pharmaceuticals, Ltd.
Similar Private Companies By Industry
|New West Genetics LLC||United States|
|Heller Biotech International, Inc.||United States|
|PerOs Systems Technologies, Inc.||United States|
|MEDgenesis Inc.||United States|
|Transplant Technologies of Texas, Ltd.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact BioMarck Pharmaceuticals, Ltd., please visit www.biomarck.com. Company data is provided by Capital IQ. Please use this form to report any data issues.